Verifying…
Home / Registered in Nigeria / Visitavag Capsules

Visitavag Capsules

NAFDAC Reg. No. A4-101097 · Drug

Registered with NAFDAC. Registration activeAs of 1 November 2026 · synced automatically from official sources.
Product
Visitavag Capsules
NAFDAC number
A4-101097
Active ingredient
Clindamycin (Clindamycin Phosphate); Clotrimazole
Strength
100 mg; 100 mg
Form
Capsule
Pack size
1 x 7's (in blister pack)
Manufacturer
Not listed
Applicant (holder)
Elbe Pharma Nigeria Limited
Approved
22 Nov 2024
Status
Active View on NAFDAC ↗
Registration valid to
21 Nov 2029
WHO alerts
None found
Community reports
None
Times checked
0

About the medicine: Clindamycin: uses, dosage and brands worldwide

What we found

  • Visitavag Capsules is on the NAFDAC register with an active registration (A4-101097). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Visitavag Capsules

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

CLINICAL STUDIES In one 12-week multicenter, randomized, evaluator-blind, vehicle-controlled, parallel comparison clinical trial in which patients used CLINDAGEL (clindamycin phosphate topical gel, 1%) once daily or the vehicle gel once daily, in the treatment of acne vulgaris of mild to moderate severity, CLINDAGEL applied once daily was more effective than the vehicle applied once daily. The mean percent reductions in lesion counts at the end of treatment in this study are shown in the following table: Lesions CLINDAGEL QD N=162 Vehicle Gel QD N=82 Inflammatory 51% 40% P

How to take it and how often
  • Apply a thin film of CLINDAGEL once daily to the skin where acne lesions appear
  • Use enough to cover the entire affected area lightly
  • Keep container tightly closed
Talk to a doctor first if

CLINDAGEL is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis.

Warnings

Orally and parenterally administered clindamycin has been associated with severe colitis, which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of topical and systemic clindamycin. Studies indicate a toxin(s) produced by Clostridia is one primary cause of antibiotic-associated colitis. The colitis is usually characterized by severe persistent diarrhea and severe abdominal cramps and may be associated with the passage of blood and mucus. Endoscopic examination may reveal pseudomembranous colitis. …

Possible side effects

In the one well-controlled clinical study comparing CLINDAGEL and its vehicle, the incidence of skin and appendages adverse events occurring in ≥1% of the patients in either group is presented in the following table: Number (%) of Patients Body System/Adverse Event CLINDAGEL QD N=168 Vehicle Gel QD N=84 Skin and Appendages Disorders Dermatitis 0 (0.0) 1 (1.2) Dermatitis contact 0 (0.0) 1 (1.2) Dermatitis fungal 0 (0.0) 1 (1.2) Folliculitis 0 (0.0) 1 (1.2) Photosensitivity reaction 0 (0.0) 1 (1.2) Pruritus 1 (0.6) 1 (1.2) Rash erythematous 0 (0.0) 0 (0.0) Skin dry 0 (0.0) 0 (0.0) Peeling 1 (0.6) 0 (0.0) Orally and parenterally administered clindamycin has been associated with severe colitis, …

If you take too much

Topically applied CLINDAGEL may be absorbed in sufficient amounts to produce systemic effects (see WARNINGS ).

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2020-01-01.

Label for clindamycin (clindamycin phosphate) and clotrimazole, the active ingredient registered with NAFDAC.

Check your pack of Visitavag Capsules

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Visitavag Capsules

What is in Visitavag Capsules?

Visitavag Capsules contains Clindamycin (Clindamycin Phosphate); Clotrimazole (100 mg; 100 mg), as capsule, according to its NAFDAC registration record.

Is Visitavag Capsules registered with NAFDAC?

Yes. Visitavag Capsules is listed on the NAFDAC register under registration number A4-101097, and its registration is active as of 1 November 2026.

Has Visitavag Capsules been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Visitavag Capsules in our automatically synced alert list.

How can I check that my pack of Visitavag Capsules is genuine?

Run a free authenticity scan with the NAFDAC number A4-101097, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Visitavag Capsules?

Follow your prescription or the leaflet in your pack. The official label says: Apply a thin film of CLINDAGEL once daily to the skin where acne lesions appear. Use enough to cover the entire affected area lightly. Keep container tightly closed.…

What is Visitavag Capsules used for?

CLINICAL STUDIES In one 12-week multicenter, randomized, evaluator-blind, vehicle-controlled, parallel comparison clinical trial in which patients used CLINDAGEL (clindamycin phosphate topical gel, 1%) once daily or the vehicle gel once daily, in the treatment of acne vulgaris of mild to moderate severity, CLINDAGEL applied once daily was more effective than the vehicle applied once daily. The mea (Summarised from the official U.S. FDA label for clindamycin (clindamycin phosphate) and clotrimazole. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Visitavag Capsules? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.